Enorama Pharma
3.06
SEK
-6.99 %
ERMA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Be the first to follow this company
-6.99%
-18.83%
-37.93%
+25.93%
+19.7%
+27.07%
-83.21%
-90.61%
-51.95%
Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are mainly sold through retailers who sell the product under their own brand. The largest market is established in the Nordic region, but also worldwide. Enorama Pharma was founded in 2006 and the head office is located in Malmö.
Read moreMarket cap
185.05M SEK
Turnover
7.31K SEK
Revenue
1.36M
EBIT %
-3,097.79 %
P/E
-
Dividend yield-%
-
Financial calendar
19/2
2025
Annual report '24
ShowingAll content types
Enorama Pharma AB (publ) utser Frida Bexelius till CFO
Enorama Pharma AB (publ) Explores Divestment of Nicotine Replacement Therapy Chewing Gum Business
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools